Clinical significance of Hepatitis B Virus (HBV) -DNA monitoring to detect HBV reactivation after systemic chemotherapy

Journal of Clinical Oncology

Volumn 29, Issue 4, 2011, Pages

  Kusumoto, Shigeru ^a   Tanaka, Yasuhito ^a   Mizokami, Masashi ^b   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RITUXIMAB; VIRUS DNA;

CANCER CHEMOTHERAPY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LARGE CELL LYMPHOMA; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC THERAPY; VIRUS LOAD; VIRUS REACTIVATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DNA, VIRAL; EARLY DIAGNOSIS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 79952085348     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.0332     Document Type: Letter

References (7)

1. Niitsu N, Hagiwara Y, Tanae K, et al: Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol 28:5097-5100, 2010
2. Westhoff TH, Jochimsen F, Schmittel A, et al: Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930, 2003
3. Allice T, Cerutti F, Pittaluga F, et al: COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: A novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 45:828-834, 2007 (Pubitemid 46427698)
4. Goedel S, Rullkoetter M, Weisshaar S, et al: Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0 in serum and plasma matrices. J Clin Virol 45:232-236, 2009
5. Fukushima N, Mizuta T, Tanaka M, et al: Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier. Ann Oncol 20:2013-2017, 2009
6. Kusumoto S, Tanaka Y, Mizokami M, et al: Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol 90:13-23, 2009
7. Yoshida T, Kusumoto S, Inagaki A, et al: Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: Two case reports. Int J Hematol 91:844-849, 2010